In situ enzyme-linked immunosorbent assay to quantitate in vitro development of Eimeria tenella.
AUTOR(ES)
Olson, J A
RESUMO
An in situ enzyme-linked immunosorbent assay was developed to measure in vitro development of Eimeria tenella. The assay used a polyclonal, anti-merozoite serum produced by immunization with culture-derived, chromatographically purified merozoites. Although this antiserum cross-reacted with sporozoite-infected cultures (by indirect immunofluorescence and in situ enzyme-linked immunosorbent assay), it clearly distinguished the increase in antigen synthesized throughout intracellular growth. The assay can be used for high-throughput, anticoccidial drug screening, for which it gives quantitative results that are comparable to the published radiometric [( 3H]uracil incorporation) endpoint.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=175995Documentos Relacionados
- Amphotericin B enzyme-linked immunosorbent assay.
- A competitive enzyme-linked immunosorbent assay to quantitate acyclovir and BW B759U in human plasma and urine.
- Indirect enzyme-linked immunosorbent assay for zygomycosis.
- Enzyme-linked immunosorbent assay for shigella toxin.
- Enzyme-linked immunosorbent assay for chlamydial antibodies.
